Boston Scientific hit with cybersecurity incident
Boston Scientific reports it has fully restored operations after a cyberattack in August forced the shutdown of plants and distribution centers. Chief Executive Officer Mike Mahoney stated at a Thursday investor conference that the company likely lost orders during the closures. The medical device manufacturer previously disclosed in an 8 September SEC warning that it is unlikely to meet its full-year 2026 sales and profit forecasts. Despite the financial setbacks, the company maintains an average buy rating from analysts polled by FactSet.
What changed
Chief Executive Officer Mike Mahoney provided new details at a Thursday investor conference confirming that the company likely lost orders during the shutdowns.
Live updates
-
Boston Scientific Restores Operations Following Cyberattack
Boston Scientific reports it has fully restored operations after a cyberattack in August forced the shutdown of plants and distribution centers. Chief Executive Officer Mike Mahoney stated at a Thursday investor conference that the company likely lost orders during the closures. The medical device manufacturer previously disclosed in an 8 September SEC warning that it is unlikely to meet its full-year 2026 sales and profit forecasts. Despite the financial setbacks, the company maintains an average buy rating from analysts polled by FactSet.
Why it matters
The operational disruption follows a sequence of setbacks for the medical device manufacturer, which also faced voluntary global recalls for its ENROUTE Transcarotid Neuroprotection systems and Suture Cinch endoscopic devices. Citigroup adjusted its price target on Boston Scientific to $57 from $61 following the disclosures, while maintaining a buy rating. The company is actively processing and shipping orders through major distribution centers to address the backlog.
What is confirmed
- Boston Scientific stated it is unlikely to meet its sales and profit forecasts for 2026 due to a cybersecurity incident.
- Boston Scientific has fully restored operations after the August cyberattack.
- Chief Executive Officer Mike Mahoney stated at a Thursday investor conference that the company likely lost orders while its plants and distribution centers were shut down.
Still unconfirmed
- Citigroup adjusted its price target on Boston Scientific to $57 from $61 and kept a buy rating.
What to watch next
- Updates on the exact financial impact of the lost orders on 2026 guidance
- Further progress reports on clearing the distribution backlog
confidence 100%Sources used for this update (4)
- health.economictimes.indiatimes.com — Boston Scientific says unlikely to meet 2026 sales, profit forecast after cyberattack
- www.marketscreener.com — Citigroup Adjusts Price Target on Boston Scientific to $57 From $61, Keeps Buy Rating
- www.thestack.technology — Runtime: The smallest Patch Tuesday of the rest of your life
- finance.yahoo.com — Boston Scientific fully restores operations after cyberattack
-
Boston Scientific restores distribution after August cyberattack
Boston Scientific has begun processing and shipping orders through major distribution centers as it works through a backlog caused by a 25 August cyberattack. The company filed a warning with the SEC on 8 September stating it is unlikely to meet its 2026 sales and profit forecasts. This operational disruption follows a period of voluntary global recalls for its ENROUTE Transcarotid Neuroprotection systems and Suture Cinch endoscopic devices, contributing to reduced full-year 2026 earnings and sales guidance.
Why it matters
The attack disabled on-premises IT systems and manufacturing, leading to a drop in share prices between 3.38% and 6%. The company is currently using third-party specialists to determine the total scope of the breach. These failures coincide with product quality issues and softer demand for key franchises.
What is confirmed
- A cyberattack on 25 August disrupted Boston Scientific global operations.
- The company is now processing and shipping orders through major distribution centers.
- Boston Scientific filed a guidance warning with the SEC on 8 September.
- The company reduced its full-year 2026 sales and earnings guidance.
- Boston Scientific issued voluntary global recalls for Suture Cinch endoscopic devices and ENROUTE Transcarotid Neuroprotection systems.
What to watch next
- Disclosure of the total scope of the data breach
- Updated third-quarter revenue figures
- Timeline for full system restoration across all global sites
confidence 100%Sources used for this update (5)
- www.medtechdive.com — Boston Scientific begins to restore shipping after cyberattack
- finance.yahoo.com — Did Recalls And Cyberattack Disruptions Just Shift Boston Scientific's (BSX) Investment Narrative?
- finance.yahoo.com — Boston Scientific on road to recovery following cyberattack
- www.financial-news.co.uk — Boston Scientific Guidance Warning Follows Cyberattack Disclosure
- www.irishexaminer.com — Boston Scientific says it's unlikely to meet 2026 sales and profit forecast after cyberattack
-
Boston Scientific investigates global operations disruption from August 25 cyberattack
Boston Scientific is working with third-party cybersecurity specialists to restore global operations after an attack detected on 25 August. The incident disabled selected on-premises information technology systems, manufacturing operations, and the processing and shipment of customer orders. The company previously reported that the outage caused share prices to fall between 3.38% and 6% and could lower third-quarter revenue by 600-700 bps. No timeline for full system restoration exists while the company continues to determine the total scope of the breach.
Why it matters
This attack is part of a broader series of cybersecurity incidents targeting the healthcare sector. Other affected entities include medical device makers Abbott, Stryker, and Medtronic, as well as drugmaker Novo Nordisk.
What is confirmed
- A cybersecurity incident detected on 25 August disrupted Boston Scientific's global operations.
- The attack affected on-premises IT systems, manufacturing, and the processing and shipment of customer orders.
- Boston Scientific is investigating the incident with third-party cybersecurity specialists.
- The outage caused share prices to drop between 3.38% and 6%.
- Third-quarter revenue may be reduced by 600-700 bps.
Still unconfirmed
- The attack may be linked to breaches affecting patient records, social security numbers, and implanted cardiac devices at multiple healthcare giants.
What to watch next
- Announcement of a timeline for full system restoration
- Disclosure of whether patient data or device functionality was compromised
- Updated third-quarter revenue figures following the recovery period
confidence 90%Sources used for this update (5)
- cyberpress.org — Boston Scientific Cyberattack Disrupts Manufacturing and Product Shipments
- economictimes.indiatimes.com — Oncology firm Novocure says cyberattack exposed US patient records
- www.yahoo.com — Multiple healthcare giants hit by data breaches affecting patient records, social security numbers, and even implanted cardiac devices
- www.digitalhealthnews.com — Boston Scientific Cyberattack Disrupts Global Operations, Order Processing
- www.medicalbrief.co.za — US device-makers, Novo, targeted in series of cyber attacks
-
Boston Scientific cyberattack disrupts manufacturing and shipping
Boston Scientific continues recovery efforts after a cyberattack disabled global shipping, ordering, and product manufacturing. The company stated in a securities filing that the full scope of the attack is still being determined. There is currently no timeline for the restoration of these systems. The outage has already caused share prices to drop between 3.38% and 6% and may reduce third-quarter revenue by 600-700 bps.
Why it matters
The company produces medical devices, meaning disruptions to manufacturing and shipping can impact healthcare providers. This incident follows a pattern of healthcare sector targeting, including a separate breach at McKesson.
What is confirmed
- The cyberattack affected the company's ability to manufacture products and process customer orders.
- Boston Scientific is still working to restore systems knocked offline by the attack.
- The company stated in a securities filing that the full scope of the incident is still being determined.
What to watch next
- Announcement of a restoration timeline for manufacturing and shipping
- Updated revenue guidance for the third quarter
- Identification of the threat actor responsible for the attack
confidence 100%Sources used for this update (7)
- startupfortune.com — Hackers Stole Data on 8.7 Million Manchester Airports Group Customers
- www.supplychaindive.com — Boston Scientific’s ordering, shipping disrupted in cyberattack
- www.medtechdive.com — Boston Scientific says cyberattack has disrupted product manufacturing
- www.securityweek.com — Boston Scientific Still Recovering From Cyberattack
- www.helpnetsecurity.com — ShinyHunters claims it stole 284 million patient records from McKesson
- techcrunch.com — Hackers claim millions of patient records stolen during data breach at healthcare giant McKesson
- www.infosecurity-magazine.com — Healthcare Giant McKesson Investigates Data Breach Incident
-
Boston Scientific global operations disrupted by August 25 cyberattack
A cyberattack detected on August 25 has halted global shipping and ordering systems for Boston Scientific. The IT outage caused company shares to drop between 3.38% and 6%. Analysts warn the incident will impact third-quarter revenue, with some estimating a potential hit of 600-700 bps. The company is currently conducting recovery efforts to restore its IT systems and resume normal business continuity.
Why it matters
Boston Scientific is a major medical technology firm. Disruptions to its shipping and order processing can delay the delivery of critical healthcare devices to providers. This incident occurs amid a broader trend of targeting the healthcare sector.
What is confirmed
- A cyberattack detected on August 25 caused global operational disruptions for Boston Scientific.
- The attack halted global shipping and ordering systems.
- Boston Scientific shares fell following the disclosure of the IT outage.
- The company's IT team is currently engaged in recovery efforts.
Still unconfirmed
- Analysts estimate a potential 600-700 bps hit to Q3 revenue.
- Shares dropped specifically by 3.38%.
- Shares fell up to 6%.
What to watch next
- Confirmation of the specific threat actor responsible for the attack
- Official Q3 revenue reports showing the actual financial impact
- Updates on the restoration of global shipping and ordering systems
confidence 90%Sources used for this update (8)
- health.economictimes.indiatimes.com — Boston Scientific hit by cyberattack, global operations affected
- www.infosecurity-magazine.com — Boston Scientific Reveals Global Disruption After Cyber Incident
- www.securityweek.com — Cyberattack Causes Global Disruption at Boston Scientific
- blockonomi.com — Boston Scientific Corporation (BSX) Stock: Slide as Cyberattack Disrupts Shipments and Operations
- startupfortune.com — Boston Scientific Shares Slide After a Cyberattack Halts Global Shipping
- www.whalesbook.com — Boston Scientific Shares Fall Up To 6% After Global IT Outage
- www.echolive.ie — Boston Scientific's IT team continues its 'recovery efforts' after cyber attack
- www.briefs.co — Industry Leaders Push for Stronger AI Cybersecurity Measures
-
Boston Scientific hit by cyberattack, global operations affected
Boston Scientific is dealing with a cybersecurity incident that has disrupted its operations, including its ability to process and ship orders. The company is working to restore its systems. Shares of Boston Scientific fell after the disclosure. The attack is expected to continue affecting parts of the company's business while recovery efforts are underway.
Why it matters
The incident has impacted the medical device company's operations globally. Boston Scientific is working to restore its systems and minimize the disruption. The company's shares fell 4% in premarket trading on Wednesday following the disclosure.
What is confirmed
- Boston Scientific was hit by a cyberattack.
- The cyberattack has disrupted the company's global operations.
- The incident has impacted the company's ability to process and ship orders.
- Shares of Boston Scientific fell after the disclosure of the cyberattack.
What to watch next
- Restoration timeline of Boston Scientific's operations
- Details on the nature and extent of the cyberattack
- Impact on Boston Scientific's customers and patients
confidence 100%Sources used for this update (11)
- Reuters — Boston Scientific hit by cyberattack, global operations affected
- Boston Scientific — Update on recent cybersecurity incident
- CNBC — Medical device maker Boston Scientific is being hit by a cyberattack. The shares are falling
- MassDevice — Boston Scientific hit with cybersecurity incident
- WSJ — Boston Scientific Stock Drops After Cyberattack
- www.bostonglobe.com — Boston Scientific hit by cyberattack, global operations affected
- www.telegram.com — Boston Scientific hit by cyberattack. Stock fell Wednesday
- finance.yahoo.com — Boston Scientific: Network outage the result of 'cybersecurity incident'
- finance.yahoo.com — Boston Scientific shares fall after cybersecurity incident disrupts operations
- thenextweb.com — Boston Scientific has disclosed a cybersecurity incident causing a global disruption to operations
- wbjournal.com — Boston Scientific hit by cyberattack, customer shipping impacted